Liver Diseases  >>  entecavir  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

12 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
entecavir / Generic mfg.
NCT01018381: Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection

Completed
N/A
130
RoW
PEIT, Pericutaneous Ethanol Injection Therapy, Pericutaneous Ethanol Injection, PEI, TOCE, Transarterial oily chemoembolization, TOCE plus PEIT, Pericutaneous ethanol injection therapy, Pericutaneous ethanol injection, TOCE plus RFA, Radiofrequency ablation, MGN-3, Peak Immune 4, BioBran, Lentin Plus 1000, Entecavir, Baraclude
The 108 Military Central Hospital, Charles Drew University of Medicine and Science
Hepatocellular Carcinoma, Hepatitis B
07/08
11/09
NCT00096811: Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program

No Longer Available
N/A
RoW
Entecavir, Baraclude
Bristol-Myers Squibb
Hepatitis B, Chronic Disease
08/08
08/08
NCT01013272: Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load

Completed
N/A
50
RoW
Entecavir, Baraclude, Lamivudine, Zeffix
The University of Hong Kong
Hepatitis B, Chronic
07/10
07/10
NCT00824707: Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer

Completed
N/A
200
RoW
Entecavir, anti-virus group, conventional therapy, control group
Eastern Hepatobiliary Surgery Hospital
Primary Liver Cancer
11/10
12/10
NCT01323452: Entecavir for Chronic Hepatitis B

Completed
N/A
418
Europe
Entecavir
Foundation for Liver Research
Entecavir for Chronic Hepatitis B Patients
01/11
03/11
NCT02075294: Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B

Completed
N/A
242
RoW
Adefovir dipivoxil or Entecavir, ADV, Hepsera,, ETV, Baraclude
Ying-Jie Ji
Hepatitis B, Chronic
10/12
10/12
NCT01813487: Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E

Completed
N/A
6
RoW
HBsAg vaccine with Entecavir
Genexine, Inc.
Chronic Hepatitis B
07/13
07/13
NCT02069678: Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B

Completed
N/A
82
RoW
Chinese University of Hong Kong
Chronic Hepatitis B
09/13
09/13
NCT01356901: Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients

Completed
N/A
230
Europe
Bristol-Myers Squibb
Hepatitis B, Chronic
01/15
01/15
HBVQuant, NCT02167113: Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay

Completed
N/A
331
Canada, US, Europe, RoW
Hologic, Inc.
Hepatitis B, Chronic
02/16
01/18
NCT01715987: Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment

Terminated
N/A
48
US
Tenofovir Disoproxil Fumarate, Viread, Entecavir, Baraclude
New Discovery LLC
Hepatitis B
05/16
05/16
NCT00388674 / 2005-003284-22: Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection

Completed
N/A
12522
Europe, Canada, US, RoW
entecavir, Baraclude, BMS-200475, Other anti-HBV medication
Bristol-Myers Squibb
Chronic Hepatitis B
10/16
10/16

Download Options